Study at Oxford University aims to find if there is a link
It only costs 10p a tablet, but a tiny white pill might have the potential to prevent cancer in patients with type 2 diabetes.
Research, by scientists at the University of Oxford and funded by the charity Diabetes UK, aims to determine if there is a connection between taking metformin and a reduction in the risk of cancer for those with type 2 diabetes .
Lead researcher, Richard Stevens, said “The complications of diabetes are commonly thought of in terms of the heart, eyes, nerves and kidneys . However some people with diabetes could also be at higher risk of developing cancer than those without the condition.”
Iain Frame, director of research at Diabetes UK, also commented “While there are various approaches to minimise the effects diabetes can have on specific organs, little is known about what preventative measures can reduce the risk people with diabetes face of developing some forms of cancer.”
He added “If it is found that metformin can help to reduce the risk people with Type 2 diabetes have of developing cancer, then this will be a big step forward in terms of how we can help people manage the condition, and hopefully allow us to develop a means to tackle the increased risk for all people with diabetes.”
But it’s not all coming up roses
I had been taking Metformin for several years before I developed breast cancer, but would love to think that this study might help others.
We will just have to be unscientific and cross our fingers!